BCK Capital Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

BCK Capital Management’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-137,459	Closed	-$869K	–	88
2022 Q4	$869K	Buy	137,459 +85,459	+164%	+$473K	0.89%	36
2022 Q3	$266K	Hold	52,000	–	–	0.19%	64
2022 Q2	$326K	Buy	+52,000	New	+$175K	0.25%	64

BCK Capital Management's FSTX Position: Q1 2023 in Review

BCK Capital Management sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 137,459 shares — an estimated $869K sold.

BCK Capital Management first reported a position in FSTX in Q2 2022 and held it in 3 quarters. The position peaked at $869K in Q4 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

BCK Capital Management reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
BCK Capital Management sold 137,459 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $869K.
BCK Capital Management first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
BCK Capital Management's F-star Therapeutics, Inc. Common Stock position peaked at $869K in Q4 2022.
0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on BCK Capital Management's 13F filing for Q1 2023, filed 12 May 2023.